ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 52 filers reported holding ANAPTYSBIO INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,348,000 | +88198.9% | 1,300,000 | 0.0% | 1.24% | +1.4% |
Q2 2023 | $26,442 | -6.5% | 1,300,000 | 0.0% | 1.23% | -11.8% |
Q1 2023 | $28,288 | -99.9% | 1,300,000 | 0.0% | 1.39% | -34.6% |
Q4 2022 | $40,287,000 | +21.5% | 1,300,000 | 0.0% | 2.12% | +13.9% |
Q3 2022 | $33,163,000 | +25.7% | 1,300,000 | 0.0% | 1.86% | +11.6% |
Q2 2022 | $26,390,000 | -17.9% | 1,300,000 | 0.0% | 1.67% | +1.1% |
Q1 2022 | $32,162,000 | -28.8% | 1,300,000 | 0.0% | 1.65% | -5.8% |
Q4 2021 | $45,175,000 | +28.1% | 1,300,000 | 0.0% | 1.76% | +42.6% |
Q3 2021 | $35,256,000 | +4.6% | 1,300,000 | 0.0% | 1.23% | +3.5% |
Q2 2021 | $33,709,000 | +20.3% | 1,300,000 | 0.0% | 1.19% | +25.2% |
Q1 2021 | $28,015,000 | +0.2% | 1,300,000 | 0.0% | 0.95% | +5.8% |
Q4 2020 | $27,950,000 | +45.8% | 1,300,000 | 0.0% | 0.90% | +35.4% |
Q3 2020 | $19,175,000 | -34.0% | 1,300,000 | 0.0% | 0.66% | -48.1% |
Q2 2020 | $29,042,000 | +58.1% | 1,300,000 | 0.0% | 1.28% | +2.0% |
Q1 2020 | $18,369,000 | -13.0% | 1,300,000 | 0.0% | 1.25% | +4.8% |
Q4 2019 | $21,125,000 | +1422.0% | 1,300,000 | +2500.0% | 1.20% | +294.4% |
Q1 2017 | $1,388,000 | – | 50,000 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |